Hepion Pharmaceuticals (HEPA) Institutional Ownership $0.62 -0.06 (-8.82%) (As of 10:26 AM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Hepion Pharmaceuticals (NASDAQ:HEPA)CurrentInstitutional OwnershipPercentage17.24%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$349.94KNumber ofInstitutional Sellers(last 12 months)0 Get HEPA Insider Trade Alerts Want to know when executives and insiders are buying or selling Hepion Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data HEPA Institutional Buying and Selling by Quarter Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Hepion Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Anson Funds Management LP231,849$155K0.0%N/A3.331% 8/15/2024 Armistice Capital LLC516,000$526K0.0%+32.3%9.428% 2/13/2024 Armistice Capital LLC418,000$1.35M0.0%+5.1%9.631% 11/15/2023 Armistice Capital LLC397,607$1.98M0.0%N/A10.360% 5/1/2023Virtu Financial LLC53,501$42K0.0%+152.8%0.070% 11/7/2022Virtu Financial LLC67,802$34K0.0%+195.6%0.089% Get the Latest News and Ratings for HEPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/13/2022PVG Asset Management Corp107,915$55K0.2%N/A0.142% 8/12/2022 Ikarian Capital LLC410,189$235K0.0%-29.5%0.538% 2/4/2022 Envestnet Asset Management Inc.72,027$82K0.0%+87.5%0.094% 2/2/2022PVG Asset Management Corp100,089$114K0.4%+92.5%0.131% 11/10/2021PVG Asset Management Corp51,989$80K0.2%-72.6%0.068% 11/9/2021BlackRock Inc.1,634,012$2.50M0.0%-1.0%2.144% 11/5/2021 PNC Financial Services Group Inc.39,034$60K0.0%N/A0.051% 10/13/2021Asset Management Corp IL ADV133,500$204K0.1%+45.9%0.175% 9/17/2021Virtu Financial LLC113,869$225K0.0%-36.4%0.149% 8/18/2021 Ikarian Capital LLC1,365,059$2.70M0.2%N/A1.791% 8/17/2021PVG Asset Management Corp189,616$375K1.2%+1,241.0%0.249% 8/17/2021 Boothbay Fund Management LLC155,069$307K0.0%N/A0.203% 8/16/2021 Morgan Stanley91,106$180K0.0%+197,956.5%0.120% 8/16/2021 State Street Corp322,716$639K0.0%N/A0.423% 8/16/2021 Goldman Sachs Group Inc.68,399$135K0.0%N/A0.090% 8/13/2021 Altium Capital Management LP446,000$883K0.2%N/A0.585% 8/13/2021 Geode Capital Management LLC651,318$1.29M0.0%+10.6%0.854% 8/11/2021BlackRock Inc.1,649,929$3.27M0.0%-3.9%2.165% 8/6/2021Asset Management Corp IL ADV91,500$181K0.1%N/A0.120% 8/4/2021 Envestnet Asset Management Inc.92,919$184K0.0%+256.9%0.122% 8/2/2021 Advisor Group Holdings Inc.17,751$35K0.0%+94.9%0.023% 8/2/2021 McAdam LLC55,978$86K0.0%+52.8%0.073% 5/19/2021Virtu Financial LLC179,030$329K0.0%N/A0.235% 5/14/2021PVG Asset Management Corp14,140$26K0.1%N/A0.019% 5/13/2021 Renaissance Technologies LLC157,500$290K0.0%-52.1%0.207% 5/13/2021 Bank of New York Mellon Corp48,602$89K0.0%+18.7%0.064% 5/12/2021 Northern Trust Corp145,515$268K0.0%+129.5%0.191% 5/12/2021 Geode Capital Management LLC588,718$1.08M0.0%+190.6%0.772% 5/12/2021 UBS Group AG68,202$125K0.0%+10,794.9%0.089% 5/11/2021 Rockefeller Capital Management L.P.20,000$36K0.0%N/A0.026% 5/10/2021 GSA Capital Partners LLP160,775$296K0.0%+80.5%0.211% 5/7/2021BlackRock Inc.1,716,168$3.16M0.0%+43.7%2.251% 5/6/2021 Prospera Financial Services Inc31,300$58K0.0%-20.4%0.041% 5/6/2021 Meitav Dash Investments Ltd.44,000$81K0.0%N/A0.058% When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away!5/4/2021 Envestnet Asset Management Inc.26,037$48K0.0%N/A0.034% 4/28/2021 JGP Wealth Management LLC15,000$28K0.0%N/A0.020% 4/26/2021 McAdam LLC36,641$67K0.0%N/A0.048% 2/17/2021 Worth Venture Partners LLC233,947$512K0.4%N/A2.592% 2/16/2021 Squarepoint Ops LLC111,978$245K0.0%+621.3%1.241% 2/12/2021 Prospera Financial Services Inc39,300$86K0.0%N/A0.435% 2/11/2021 Northern Trust Corp63,402$139K0.0%N/A0.703% 2/10/2021 Renaissance Technologies LLC329,022$721K0.0%N/A3.646% 2/9/2021 Perkins Capital Management Inc.150,000$329K0.2%N/A1.662% 2/9/2021 Bank of New York Mellon Corp40,945$90K0.0%N/A0.454% 2/5/2021BlackRock Inc.1,194,434$2.62M0.0%+1,867.1%13.235% 2/4/2021 GSA Capital Partners LLP89,067$195K0.0%N/A0.987% 1/19/2021 Allen Capital Group LLC23,685$52K0.0%N/A0.262% 11/16/2020 ExodusPoint Capital Management LP11,632$36K0.0%N/A0.129% (Data available from 1/1/2016 forward) HEPA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of HEPA shares? During the previous two years, the following institutional investors and hedge funds held shares of Hepion Pharmaceuticals shares: Armistice Capital LLC ($526K), and Anson Funds Management LP ($155K), Virtu Financial LLC ($42K).Learn more on HEPA's institutional investors. What percentage of Hepion Pharmaceuticals stock is owned by institutional investors? 17.24% of Hepion Pharmaceuticals stock is owned by institutional investors. Learn more on HEPA's institutional investor holdings. Which institutional investors have been buying Hepion Pharmaceuticals stock? The following institutional investors have purchased Hepion Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($544K), Anson Funds Management LP ($231.85K), and Virtu Financial LLC ($32.34K). How much institutional buying is happening at Hepion Pharmaceuticals? Institutional investors have bought a total of 808,185 shares in the last 24 months. This purchase volume represents approximately $2.84M in transactions. Related Companies PMCB Major Shareholders PRPH Major Shareholders SNSE Major Shareholders IPA Major Shareholders NRXP Major Shareholders AWH Major Shareholders TSBX Major Shareholders AVTX Major Shareholders TRIB Major Shareholders HCWB Major Shareholders This page (NASDAQ:HEPA) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredFREE investing Class TOMORROW + 2 FREE BonusesOver the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...Unstoppable Prosperity | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored🗓️ My First LIVE Event in 5 Years!Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hepion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hepion Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HEPA Stock Alerts